- Home
- FRHC vs LNTH Comparison
FRHC vs LNTH Comparison
Compare FRHC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRHC
- LNTH
- Stock Information
- Founded
- FRHC 1981
- LNTH 1956
- Country
- FRHC Kazakhstan
- LNTH United States
- Employees
- FRHC N/A
- LNTH N/A
- Industry
- FRHC Investment Bankers/Brokers/Service
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FRHC Finance
- LNTH Health Care
- Exchange
- FRHC Nasdaq
- LNTH Nasdaq
- Market Cap
- FRHC 7.2B
- LNTH 6.0B
- IPO Year
- FRHC N/A
- LNTH 2015
- Fundamental
- Price
- FRHC $146.11
- LNTH $78.23
- Analyst Decision
- FRHC
- LNTH Strong Buy
- Analyst Count
- FRHC 0
- LNTH 6
- Target Price
- FRHC N/A
- LNTH $132.67
- AVG Volume (30 Days)
- FRHC 104.1K
- LNTH 847.6K
- Earning Date
- FRHC 02-07-2025
- LNTH 02-26-2025
- Dividend Yield
- FRHC N/A
- LNTH N/A
- EPS Growth
- FRHC N/A
- LNTH 304.57
- EPS
- FRHC 5.36
- LNTH 6.02
- Revenue
- FRHC $1,578,152,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- FRHC N/A
- LNTH $19.64
- Revenue Next Year
- FRHC N/A
- LNTH $5.16
- P/E Ratio
- FRHC $27.28
- LNTH $12.99
- Revenue Growth
- FRHC 79.07
- LNTH 24.15
- 52 Week Low
- FRHC $64.00
- LNTH $56.44
- 52 Week High
- FRHC $164.83
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- FRHC 49.94
- LNTH 31.32
- Support Level
- FRHC $148.41
- LNTH $79.39
- Resistance Level
- FRHC $157.60
- LNTH $84.24
- Average True Range (ATR)
- FRHC 6.13
- LNTH 3.84
- MACD
- FRHC -0.65
- LNTH -0.93
- Stochastic Oscillator
- FRHC 28.61
- LNTH 0.66
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.